1. Home
  2. GNLX vs CENX Comparison

GNLX vs CENX Comparison

Compare GNLX & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • CENX
  • Stock Information
  • Founded
  • GNLX 2001
  • CENX 1995
  • Country
  • GNLX United States
  • CENX United States
  • Employees
  • GNLX N/A
  • CENX N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • CENX Aluminum
  • Sector
  • GNLX Health Care
  • CENX Industrials
  • Exchange
  • GNLX Nasdaq
  • CENX Nasdaq
  • Market Cap
  • GNLX 96.6M
  • CENX 1.8B
  • IPO Year
  • GNLX 2023
  • CENX 1996
  • Fundamental
  • Price
  • GNLX $2.87
  • CENX $18.02
  • Analyst Decision
  • GNLX Strong Buy
  • CENX Strong Buy
  • Analyst Count
  • GNLX 4
  • CENX 3
  • Target Price
  • GNLX $17.75
  • CENX $23.00
  • AVG Volume (30 Days)
  • GNLX 151.1K
  • CENX 1.8M
  • Earning Date
  • GNLX 08-13-2025
  • CENX 08-07-2025
  • Dividend Yield
  • GNLX N/A
  • CENX N/A
  • EPS Growth
  • GNLX N/A
  • CENX N/A
  • EPS
  • GNLX N/A
  • CENX 1.22
  • Revenue
  • GNLX N/A
  • CENX $2,364,700,000.00
  • Revenue This Year
  • GNLX N/A
  • CENX $7.19
  • Revenue Next Year
  • GNLX N/A
  • CENX $3.99
  • P/E Ratio
  • GNLX N/A
  • CENX $14.79
  • Revenue Growth
  • GNLX N/A
  • CENX 11.41
  • 52 Week Low
  • GNLX $1.60
  • CENX $11.40
  • 52 Week High
  • GNLX $5.89
  • CENX $25.39
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 52.48
  • CENX 53.93
  • Support Level
  • GNLX $2.75
  • CENX $16.90
  • Resistance Level
  • GNLX $3.17
  • CENX $17.89
  • Average True Range (ATR)
  • GNLX 0.25
  • CENX 0.75
  • MACD
  • GNLX 0.01
  • CENX -0.19
  • Stochastic Oscillator
  • GNLX 44.74
  • CENX 43.19

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

Share on Social Networks: